Published in Surg Endosc on August 21, 2007
Laparoscopic surgery for cancer: a systematic review and a way forward. J Am Coll Surg (2010) 1.58
Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) (2010) 1.51
Laparoscopic liver resection. World J Surg (2011) 1.38
Laparoscopic versus open liver segmentectomy: prospective, case-matched, intention-to-treat analysis of clinical outcomes and cost effectiveness. Surg Endosc (2008) 1.36
Short- and long-term outcomes after laparoscopic and open hepatic resection: systematic review and meta-analysis. HPB (Oxford) (2011) 1.23
Laparoscopic hepatectomy: a systematic review, meta-analysis, and power analysis. Surg Today (2010) 0.99
Single-port laparoscopic hepatectomy: technique, safety, and feasibility in a clinical case series. Surg Endosc (2011) 0.99
Laparoscopic liver resection: Experience based guidelines. World J Gastrointest Surg (2016) 0.96
Open liver resection for colorectal metastases: better short- and long-term outcomes in patients potentially suitable for laparoscopic liver resection. HPB (Oxford) (2010) 0.88
Complications of liver resection: laparoscopic versus open procedures. JSLS (2013) 0.87
Has laparoscopy increased surgical indications for benign tumors of the liver? Langenbecks Arch Surg (2012) 0.87
Risk factors and management of conversions to an open approach in laparoscopic liver resection: analysis of 265 consecutive cases. HPB (Oxford) (2013) 0.85
Traditional versus robot-assisted full laparoscopic liver resection: a matched-pair comparative study. World J Surg (2014) 0.84
National trends in the use of surgery for benign hepatic tumors in the United States. Surgery (2015) 0.83
Hepatocellular adenoma: an excellent indication for laparoscopic liver resection. HPB (Oxford) (2012) 0.83
Gallbladder cancer: role of laparoscopy in the management of potentially resectable tumors. Surg Endosc (2010) 0.82
Initial experience in single-incision transumbilical laparoscopic liver resection: indications, potential benefits, and limitations. HPB Surg (2012) 0.81
A survey in the hepatopancreatobiliary community on ways to enhance patient recovery. HPB (Oxford) (2012) 0.80
Colorectal cancer liver metastases: laparoscopic and open radiofrequency-assisted surgery. Wideochir Inne Tech Maloinwazyjne (2015) 0.77
Tissue management with tri-staple technology in major and minor laparoscopic liver resections. Int Surg (2014) 0.76
Less cost by using hanging maneuver and Pringle maneuver in left lateral hepatectomy through small laparotomy wound-experience of Southern Taiwan. World J Surg Oncol (2016) 0.75
Three trocars laparoscopic resection of angiomyolipoma of the liver. Int J Hepatol (2011) 0.75
Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg (2005) 3.29
Laparoscopic liver resections: a feasibility study in 30 patients. Ann Surg (2000) 3.01
Laparoscopic versus open hepatic resections for benign and malignant neoplasms--a meta-analysis. Surgery (2006) 2.43
[Laparoscopic hepatectomy]. Ann Chir (2002) 2.41
Laparoscopic liver resection. Br J Surg (2006) 2.36
Laparoscopic anatomical (hepatic) left lateral segmentectomy-technical aspects. Surg Endosc (1996) 2.33
Laparoscopic versus open left lateral hepatic lobectomy: a case-control study. J Am Coll Surg (2003) 2.13
[Factors influencing the development of incisional hernia. A retrospective study of 2,983 laparotomy patients over a period of 10 years]. Chirurg (2002) 2.11
Laparoscopic vs open hepatic resection: a comparative study. Surg Endosc (2003) 1.87
Benign liver tumors: differential diagnosis and indications for surgery. World J Surg (1997) 1.83
Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology (1995) 1.78
Laparoscopic liver resection compared with conventional partial hepatectomy--a prospective analysis. Hepatogastroenterology (1999) 1.70
Laparoscopic management of benign solid and cystic lesions of the liver. Ann Surg (1999) 1.70
Laparoscopic liver resection of benign liver tumors. Surg Endosc (2002) 1.68
Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg (1988) 1.61
Laparoscopy as a routine approach for left lateral sectionectomy. Br J Surg (2007) 1.60
Laparoscopic liver surgery: Shifting the management of liver tumors. Hepatology (2006) 1.58
Laparoscopic anatomical hepatic resection. Report of four left lobectomies for solid tumors. Surg Endosc (1998) 1.41
Oral-contraceptive-associated liver tumours: occurrence of malignancy and difficulties in diagnosis. Lancet (1980) 1.37
Natural history of hepatic haemangiomas: clinical and ultrasound study. Gut (1991) 1.36
Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma. World J Surg (1995) 1.35
Cavernous hemangiomas of the liver: are there any indications for resection? World J Surg (1995) 1.30
The metabolic and immune response to laparoscopic versus open liver resection. Surg Endosc (2002) 1.28
An initial experience and evolution of laparoscopic hepatic resectional surgery. Surgery (2004) 1.26
Selective management of hepatic adenomas. Am Surg (1996) 1.24
Natural history of focal nodular hyperplasia of the liver: an ultrasound study. J Clin Ultrasound (1996) 1.22
Prospective assessment of the safety and benefit of laparoscopic liver resections. J Hepatobiliary Pancreat Surg (2002) 1.14
Focal nodular hyperplasia of the liver: results of treatment and options in management. Gut (1991) 1.12
Colon cancer seeding after percutaneous fine needle aspiration of liver metastasis. J Hepatol (1993) 0.97
Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology (1994) 0.97
Oral contraceptive-associated liver cell adenoma and hepatocellular carcinoma. Cytomorphology and mechanism of malignant transformation. Cancer (1991) 0.95
Benign tumors of the liver resected because of a diagnosis of malignancy. Surg Gynecol Obstet (1992) 0.90
Diagnosis of focal nodular hyperplasia of the liver by needle biopsy. Hum Pathol (2005) 0.80
Diagnostic approach to a liver mass: diagnosis of an asymptomatic liver tumor in a young woman. J Hepatol (1996) 0.75
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study. Lancet Oncol (2012) 3.88
Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology (2005) 3.72
Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection. Gastroenterology (2002) 2.54
Similar compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug use in comparison with other infection causes. Eur J Gastroenterol Hepatol (2006) 2.47
Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology (2012) 2.46
Angiogenesis in liver disease. J Hepatol (2008) 2.31
Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med (2004) 2.29
Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell (2010) 2.26
Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology (2004) 1.99
Experimental mouse models for hepatocellular carcinoma research. Int J Exp Pathol (2009) 1.79
Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg (2004) 1.79
A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C. Hepatology (2003) 1.73
Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial. Langenbecks Arch Surg (2005) 1.69
Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice. Hepatology (2011) 1.65
Open intraperitoneal versus retromuscular mesh repair for umbilical hernias less than 3 cm diameter. Am J Surg (2010) 1.60
First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantation. Transplantation (2010) 1.58
Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion. Liver Transpl (2006) 1.57
ABO-mismatch adult living donor liver transplantation using antigen-specific immunoadsorption and quadruple immunosuppression without splenectomy. Liver Transpl (2006) 1.57
188Re-HDD/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial. J Nucl Med (2005) 1.52
Intra-arterial treatment with ⁹⁰Y microspheres for hepatocellular carcinoma: 4 years experience at the Ghent University Hospital. Eur J Nucl Med Mol Imaging (2011) 1.50
Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer. Int J Radiat Oncol Biol Phys (2004) 1.50
Laparoscopic evaluation shows deficiencies in memory ring deployment during small ventral hernia repair. World J Surg (2010) 1.49
Alteration of protein glycosylation in liver diseases. J Hepatol (2008) 1.47
Pancreatic metastases from renal cell carcinoma: the state of the art. World J Gastroenterol (2011) 1.46
Angiogenesis in chronic liver disease and its complications. Liver Int (2010) 1.41
Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: an analysis of cutoff values. Liver Transpl (2013) 1.41
Laparoscopic radiofrequency ablation in the caudate lobe for hepatocellular carcinoma before liver transplantation. J Laparoendosc Adv Surg Tech A (2012) 1.40
Time-dependent changes in 18F-FDG activity in the thymus and bone marrow following combination chemotherapy in paediatric patients with lymphoma. Eur J Nucl Med Mol Imaging (2009) 1.37
Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label study. J Hepatol (2012) 1.35
Dose reduction in patients undergoing chest imaging: digital amorphous silicon flat-panel detector radiography versus conventional film-screen radiography and phosphor-based computed radiography. AJR Am J Roentgenol (2003) 1.33
Use of topical hemostatic agents during liver resection. Dig Surg (2007) 1.31
Effects of hemi-portocaval shunts for inflow modulation on the outcome of small-for-size grafts in living donor liver transplantation. Am J Transplant (2005) 1.26
Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation? Ann Surg (2003) 1.26
The paradox of the unfolded protein response in cancer. Anticancer Res (2013) 1.21
Robot assistance in liver surgery: a real advantage over a fully laparoscopic approach? Results of a comparative bi-institutional analysis. Int J Med Robot (2013) 1.19
Transinguinal preperitoneal memory ring patch versus Lichtenstein repair for unilateral inguinal hernias. Langenbecks Arch Surg (2009) 1.18
Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours. Eur J Nucl Med Mol Imaging (2012) 1.16
Hemostatic efficacy of TachoSil in liver resection compared with argon beam coagulator treatment: an open, randomized, prospective, multicenter, parallel-group trial. Surgery (2010) 1.15
Hepatic resection for primary or secondary malignancies with involvement of the inferior vena cava: is this operation safe or hazardous? J Am Coll Surg (2005) 1.11
Diagnostic value of the hemopexin N-glycan profile in hepatocellular carcinoma patients. Clin Chem (2010) 1.09
Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model. Int J Radiat Oncol Biol Phys (2006) 1.07
Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation. Int J Exp Pathol (2008) 1.02
Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis. J Proteome Res (2009) 1.00
Dose-length product of scanners correlates with DNA damage in patients undergoing contrast CT. Eur J Radiol (2011) 0.99
Adenocarcinoid tumor of the extrahepatic biliary tract. Int J Surg Pathol (2008) 0.98
Vascular corrosion casting: analyzing wall shear stress in the portal vein and vascular abnormalities in portal hypertensive and cirrhotic rodents. Lab Invest (2010) 0.98
Evolution of laparoscopic left lateral sectionectomy without the Pringle maneuver: through resection of benign and malignant tumors to living liver donation. Surg Endosc (2010) 0.97
Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: a European multicentric case-control study. Transplantation (2011) 0.97
Liver metastases from colorectal cancer: present surgical approach. Hepatogastroenterology (2003) 0.95
Clinical relevance of adapting portal vein flow in living donor liver transplantation in adult patients. Liver Transpl (2003) 0.95
Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection. Clin Chim Acta (2005) 0.95
Perioperative factors determine outcome after surgery for severe acute pancreatitis. Crit Care (2004) 0.94
Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation. World J Gastroenterol (2013) 0.94
Cystic pancreatic neuroendocrine neoplasms with uncertain malignant potential: report of two cases. Surg Today (2009) 0.93
An intravital microscopic study of the hepatic microcirculation in cirrhotic mice models: relationship between fibrosis and angiogenesis. Int J Exp Pathol (2008) 0.93
Normal uptake of F-18 FDG in the testis as assessed by PET/CT in a pediatric study population. Ann Nucl Med (2009) 0.93
Primary squamous cell carcinoma of the liver associated with Caroli's disease: a case report. Onkologie (2011) 0.93
Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study. Liver Int (2006) 0.93
F-18 fluorodeoxyglucose PET/CT scanning in the diagnostic work-up of a primary pericardial mesothelioma: a case report. J Thorac Imaging (2008) 0.92
Hemodynamic changes in splanchnic blood vessels in portal hypertension. Anat Rec (Hoboken) (2008) 0.92
Subfulminant hepatitis B during treatment with adalimumab in a patient with rheumatoid arthritis and chronic hepatitis B. Eur J Gastroenterol Hepatol (2010) 0.91
Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma. Mol Cancer (2010) 0.91
Monoclonal antibody 14C5 targets integrin alphavbeta5. Mol Cancer Ther (2008) 0.90
Effects of portal vein arterialization on liver regeneration after partial hepatectomy in the rat. Liver Transpl (2002) 0.90
The placental growth factor as a target against hepatocellular carcinoma in a diethylnitrosamine-induced mouse model. J Hepatol (2012) 0.90
FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus. World J Gastroenterol (2011) 0.90
Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients. Liver Int (2004) 0.90
Lack of a correlation between portal vein flow and pressure: toward a shared interpretation of hemodynamic stress governing inflow modulation in liver transplantation. Liver Transpl (2011) 0.89
Image quality performance of liquid crystal display systems: influence of display resolution, magnification and window settings on contrast-detail detection. Eur J Radiol (2006) 0.89
Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models. Hepatology (2013) 0.89
Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions? Acta Gastroenterol Belg (2008) 0.89
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival. Cancer Invest (2008) 0.89
Oral fluid as a medium for the detection of hepatitis B surface antigen. J Med Virol (2005) 0.89
Multimodal treatment of hepatocellular carcinoma on cirrhosis: an update. World J Gastroenterol (2013) 0.89